BrachySciences recently introduced its AnchorSeed, which features a patent pending design intended to give existing low dose rate prostate brachytherapy sources the ability to maintain their position within tissue, thereby allowing physicians to confidently place seeds in more strategic and beneficial locations than in the past.

The Piranha and Barracuda reportedly offer a complete range of capabilities to measure the important QA parameters on all types of X-ray systems. Both are based on solid-state technology. The Barracuda has available bias voltage for the use of ionization chambers.

Bionix Radiation Therapy’s Prone Breast System utilizes prone positioning for breast treatment to deliver less irradiation to the lung, cardiac tissue and contralateral breast. Gravity is utilized to separate cancerous masses from surrounding lung and cardiac tissue and for greater reproducibility of the breast being treated.

Elekta recently received FDA clearance for its Volumetric Modulated Arc Therapy (VMAT). Reportedly empowering clinicians ...

TQA, or Tomo Quality Assurance, is reportedly the first integrated, machine-specific quality assurance (QA) solution to be offered by a radiation therapy vendor. The TQA application streamlines the collection and simplifies the review of data used to monitor radiation therapy equipment and procedures. All TQA data can be exported for third-party validation.

The Eclipse treatment planning system is a comprehensive solution designed to simplify modern radiation therapy planning for all kinds of treatment, including 3D conformal, intensity-modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), RapidArc volumetric modulated arc, electron, proton and brachytherapy treatments.

Varian Medical Systems will be exhibiting its complete line of hardware, software, and applicators for HDR and LDR brachytherapy, including the VariSource iX, GammaMedplus iX and the GammaMedplus 3/24 iX HDR afterloaders, the BrachyVision treatment planning system plus the Vitesse module for using transrectal ultrasound (TRUS) images as the basis for a prostate cancer treatment plan.